An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year. Subscribe…
![Sweden's chief epidemiologist: 'We are happy with our strategy' on Covid-19 Sweden's chief epidemiologist: 'We are happy with our strategy' on Covid-19](https://www.vitaminrush.com/wp-content/uploads/2020/10/1602088564_hqdefault.jpg)